Stem Cells Blog

Fabrizio Rinaldi, PhD, Scientist in Stem Cell Research and Development, Bio-Techne
Tim Manning, PhD, Proteins Product Manager, Bio-Techne

We have captured this month’s most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Standardized pluripotent stem cell differentiation kits, such as the StemXVivo^® Differentiation Kits from R&D Systems, offer a number of benefits over both home-brew protocols or the direct purchase of pre-differentiated iPS cells. This post provides a brief discussion of those benefits:

Joy Aho, PhD, Manager of Stem Cells Research and Development Bio-Techne
Ernesto Resnik, PhD, Manager of Antibody Research and Development Bio-Techne

Mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) are being utilized for the development of multitude of regenerative therapies. Establishing standards and practices for characterizing MSCs and iPSCs is an important quality issue for the future of stem cell research and regenerative medicine. Simple steps can be taken to improve the quality and efficiency of both MSC and iPSC expansion and differentiation.

Joy Aho, PhD, Manager of Stem Cell Research and Development, Bio-Techne
Richard Fuerstenberg, Manager of Multiplex Development, Bio-Techne

Madeline Lancaster, PhD, MRC Laboratory of Molecular Biology
Omer Yilmaz, PhD, Assistant Professor of Biology, MIT
Sri Devi Narasimhan, Scientific Editor, Cell
Marie Bao, Editor, Developmental Cell